16 Pharma Companies Using Artificial Intelligence in Drug Discovery

GSK is probably the most active of all pharmaceutical companies in applying artificial intelligence to drug discovery. It created an in-house artificial intelligence unit. Now called "In silico Drug Discovery Unit.") And it has partnered with startups including Exscientia and Insilico Medicine. The partnership with Excscientia, announced in July 2017, is to discover novel and selective small molecules for up to 10 disease-related targets across undisclosed therapeutic areas.